Prostaglandin
| Product | Indication | Specification | Regulatory status |
|---|---|---|---|
| Alprostadil | 1. Cyanotic congenital heart disease for pediatrics 2. Peripheral Arterial Occlusive Disease 3. Erectile dysfunction |
USP / EP / CN | US DMF / CEP / China Reg. No. / Canada DMF |
| Epoprostenol Sodium | Primary Pulmonary Hypertension | In-house | ASMF/China Reg. No. / Canada DMF |
| Limaprost alfadex | 1. Ischemic symptoms 2. Lumbar spinal canal stenosis |
JP | China Reg. No. * |
| Lubiprostone | Chronic idiopathic constipation | In-house | US DMF |
| Misoprostol | 1. NSAID-induced Ulcers 2. Gastric/Duodenal Ulcers 3. Labour Induction |
USP/EP | US DMF/ ASMF/ Australia DMF |
| Misoprostol-HPMC 1% Dispersion | 1. NSAID-induced Ulcers 2. Gastric/Duodenal Ulcers 3. Labour Induction |
In-house / USP | US DMF/ ASMF/ Australia DMF China Reg. No. / Canada DMF |
| Treprostinil Diolanime | Pulmonary Arterial Hypertension | In-house | US DMF |
| Bimatoprost | Glaucoma | In-house | US DMF/ ASMF / Canada DMF/ Japan DMF |
| Latanoprost | In-house / USP | US DMF/ ASMF / Japan DMF/ Australia DMF / China IDL / Canada DMF |
|
| Latanoprostene Bunod | In-house | none | |
| Travoprost | USP | none | |
| Tafluprost | In-house | US DMF |
* In process